HSD17B13 and non-alcoholic fatty liver: A recent GWAS on non-alcoholic fatty liver and steatohepatitis by Anstee et al.26 highlighted the role of PNPLA3, TM6SF2, GCKR, PYGO1, HSD17B13, and LEPR in these liver disorders.